Promoting emerging medical solutions for women to improve diagnostics and treatment

The inaugural MedFemTech Congress connects and engages key players in the female medical technology sector, launching a global community of medical professionals, innovators, investors, and other experts from across the health care ecosystem–from patients to doctors to investors, career medical professionals, and tech visionaries–representing hospitals, clinics, academia, and technology solution companies.

The overall FemTech market was valued at $18.7B in 2019 and is projected to reach $60.1B by 2027, with a CAGR of over 15.6%. The industry remains underestimated

Over 1,500 companies have been classified as MedFemTech, categorized into 14 subsectors and 8 aggregated subsectors by application. Of the total market, pregnancy is the largest one.
 

• Maternal health, prenatal care, and breastfeeding
• Menstrual health
• Pelvic, sexual, and other gyn
• Reproductive health, assisted reproduction technologies
• Endometriosis, pelvic floor, sexual health
• Women's Cancer, Breast cancer and reconstruction, ovarian cancer, cervical cancer
• Menopause, peri, and post-menopausal symptoms
• Contraception, oral contraceptives, and IUDs
• Gynaecological infections, bacterial vaginosis, Human papillomavirus (HPV), sexually transmitted disease
• Longevity
• Diagnostics
• AI for women's health
• Women mental health
• Advanced medicine for women